These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 14760085)

  • 1. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
    Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
    Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation-deficient DeltaTA-p73 acts as an oncogene.
    Stiewe T; Zimmermann S; Frilling A; Esche H; Pützer BM
    Cancer Res; 2002 Jul; 62(13):3598-602. PubMed ID: 12097259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.
    Stiewe T; Theseling CC; Pützer BM
    J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells.
    Sayan AE; Sayan BS; Findikli N; Ozturk M
    Oncogene; 2001 Aug; 20(37):5111-7. PubMed ID: 11526499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of DeltaTA-p 73 splice transcripts during melanoma development and progression.
    Tuve S; Wagner SN; Schittek B; Pützer BM
    Int J Cancer; 2004 Jan; 108(1):162-6. PubMed ID: 14618632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia.
    Meier M; den Boer ML; Meijerink JP; Broekhuis MJ; Passier MM; van Wering ER; Janka-Schaub GE; Pieters R
    Leukemia; 2006 Aug; 20(8):1377-84. PubMed ID: 16791269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
    Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
    J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria.
    Schuster A; Schilling T; De Laurenzi V; Koch AF; Seitz S; Staib F; Teufel A; Thorgeirsson SS; Galle P; Melino G; Stremmel W; Krammer PH; Müller M
    Cell Cycle; 2010 Jul; 9(13):2629-39. PubMed ID: 20581467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
    Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
    J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p73 is up-regulated in a subset of hepatocellular carcinomas.
    Herath NI; Kew MC; Whitehall VL; Walsh MD; Jass JR; Khanna KK; Young J; Powell LW; Leggett BA; Macdonald GA
    Hepatology; 2000 Mar; 31(3):601-5. PubMed ID: 10706549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcript.
    Pützer BM; Tuve S; Tannapfel A; Stiewe T
    Cell Death Differ; 2003 May; 10(5):612-4. PubMed ID: 12728260
    [No Abstract]   [Full Text] [Related]  

  • 13. C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.
    Racek T; Mise N; Li Z; Stoll A; Pützer BM
    J Biol Chem; 2005 Dec; 280(49):40402-5. PubMed ID: 16234237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiregulin induces the alternative splicing of p73 into its oncogenic isoform DeltaEx2p73 in human hepatocellular tumors.
    Castillo J; Goñi S; Latasa MU; Perugorría MJ; Calvo A; Muntané J; Bioulac-Sage P; Balabaud C; Prieto J; Avila MA; Berasain C
    Gastroenterology; 2009 Nov; 137(5):1805-15.e1-4. PubMed ID: 19664633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
    Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
    J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
    Faridoni-Laurens L; Bosq J; Janot F; Vayssade M; Le Bihan ML; Kaghad M; Caput D; Bénard J; Ahomadegbe JC
    Oncogene; 2001 Aug; 20(38):5302-12. PubMed ID: 11536043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
    Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
    J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
    Pan H; Liao SJ; Lai WY; Lu HC; Hsiao KM
    Acta Oncol; 2002; 41(6):550-5. PubMed ID: 12546528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.
    Emmrich S; Wang W; John K; Li W; Pützer BM
    Mol Cancer; 2009 Aug; 8():61. PubMed ID: 19671150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.